Comments
Dr Reddy's Laboratories has announced that its chemical manufacturing facility at Cuernavaca, Mexico, has received a four-item warning letter from the United States Food and Drug Authority (USFDA).
The USFDA inspected Dr Reddy's Mexico facility in November 2010. That inspection resulted in issuance of form FDA 483 with observations. Dr Reddy's said that it responded to the 483 observation by implementing a number of corrective actions.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.